Ilka Petry

471 total citations
9 papers, 158 citations indexed

About

Ilka Petry is a scholar working on Oncology, Surgery and Urology. According to data from OpenAlex, Ilka Petry has authored 9 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Surgery and 2 papers in Urology. Recurrent topics in Ilka Petry's work include Pelvic floor disorders treatments (2 papers), Urinary Tract Infections Management (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). Ilka Petry is often cited by papers focused on Pelvic floor disorders treatments (2 papers), Urinary Tract Infections Management (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). Ilka Petry collaborates with scholars based in Germany and United Kingdom. Ilka Petry's co-authors include Heinz Koelbl, Alexander Puhl, Christine Skala, Gert Naumann, Stefan Albrich, Jan G. Hengstler, Wiebke Schormann, Susanne Gebhard, Matthias Hermes and Marc Brulport and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Diabetologia.

In The Last Decade

Ilka Petry

9 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ilka Petry Germany 7 62 50 45 32 22 9 158
Atsushi Kyan Japan 7 110 1.8× 37 0.7× 16 0.4× 10 0.3× 6 0.3× 17 189
Jinyeong Lim South Korea 7 76 1.2× 37 0.7× 46 1.0× 17 0.5× 11 0.5× 18 157
Marcin M. Machnicki Poland 8 55 0.9× 36 0.7× 16 0.4× 11 0.3× 14 0.6× 25 142
Isabela W. Cunha Brazil 8 159 2.6× 57 1.1× 92 2.0× 7 0.2× 7 0.3× 14 301
B Dębniak Poland 9 87 1.4× 103 2.1× 52 1.2× 5 0.2× 11 0.5× 11 229
Marie Nollet France 8 106 1.7× 41 0.8× 27 0.6× 5 0.2× 5 0.2× 13 167
Masafumi Sada Japan 7 64 1.0× 136 2.7× 71 1.6× 9 0.3× 14 0.6× 15 221
C. Truica United States 4 282 4.5× 74 1.5× 35 0.8× 11 0.3× 8 0.4× 9 358
Brian C. Willis United States 7 79 1.3× 162 3.2× 52 1.2× 9 0.3× 41 1.9× 9 305
Sanket Shah India 11 186 3.0× 69 1.4× 41 0.9× 12 0.4× 16 0.7× 26 323

Countries citing papers authored by Ilka Petry

Since Specialization
Citations

This map shows the geographic impact of Ilka Petry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilka Petry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilka Petry more than expected).

Fields of papers citing papers by Ilka Petry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilka Petry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilka Petry. The network helps show where Ilka Petry may publish in the future.

Co-authorship network of co-authors of Ilka Petry

This figure shows the co-authorship network connecting the top 25 collaborators of Ilka Petry. A scholar is included among the top collaborators of Ilka Petry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilka Petry. Ilka Petry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kölbl, H., et al.. (2011). p53 is correlated with low BMI negative progesterone receptor status and recurring disease in patients with endometrial cancer. Gynecologic Oncology. 125(1). 200–207. 6 indexed citations
2.
Schmidt, Maria A., Ilka Petry, Daniel Boehm, et al.. (2011). Disparities in the prognostic significance of proliferation amongst different molecular subtypes in node-negative breast cancer.. Journal of Clinical Oncology. 29(15_suppl). 10566–10566. 1 indexed citations
3.
Schmidt, Marcus, Ilka Petry, Daniel Böhm, et al.. (2010). Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer. Breast Cancer Research and Treatment. 125(3). 637–646. 29 indexed citations
4.
Skala, Christine, Ilka Petry, Stefan Albrich, et al.. (2010). The effect of genital and lower urinary tract symptoms on steroid receptor expression in women with genital prolapse. International Urogynecology Journal. 22(6). 705–712. 15 indexed citations
5.
Petry, Ilka, Marcus Schmidt, Mathias Gehrmann, et al.. (2010). ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer. Clinical Cancer Research. 16(2). 451–460. 37 indexed citations
6.
Skala, Christine, Ilka Petry, Stefan Albrich, et al.. (2010). The effect of hormonal status on the expression of estrogen and progesterone receptor in vaginal wall and periurethral tissue in urogynecological patients. European Journal of Obstetrics & Gynecology and Reproductive Biology. 153(1). 99–103. 21 indexed citations
7.
Skala, Christine, Ilka Petry, Susanne Gebhard, et al.. (2009). Isolation of Fibroblasts for Coating of Meshes for Reconstructive Surgery: Differences Between Mesh Types. Regenerative Medicine. 4(2). 197–204. 12 indexed citations
8.
Steiner, Eric, K. Pollow, Dirk Hasenclever, et al.. (2008). Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer. Gynecologic Oncology. 108(3). 569–576. 36 indexed citations
9.
Illner, W.-D., D. Abendroth, H. Schneeberger, et al.. (1991). Outcome of renal grafts after simultaneous kidney/ pancreas transplantation. Diabetologia. 34(S1). S16–S17. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026